Optimus Pharma seeks nod for phase-3 trials of generic Molnupiravir
April 26, 2021 For checking efficacy across demographics Optimus Pharma has applied for emergency approval for Phase 3 clinical trial of its generic version of Molnupiravir from the Drugs Controller General of India. “Phase 2a clinical trial study on enrolled 202 non-hospitalised adults is already made available. Virological analysis was characterized by marked decrease in positive viral culture in subjects who received Molnupiravir (all doses) relative to placebo - at day 5: 0% (0/47) for Molnupiravir and 24 pc (6/25) for placebo,’’ the Hyderabad-based company said in a release. Fu...